http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-101765335-B1
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C08G69-08 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C08G69-40 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K49-1857 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C08G81-00 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K49-08 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K49-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K49-06 |
| filingDate | 2014-09-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2017-08-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2017-08-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | KR-101765335-B1 |
| titleOfInvention | MRI Contrast Agent for Contrasting Cancer Cell |
| abstract | The present invention relates to an MRI contrast agent composition for cancer cell imaging containing ultrafine nanoparticles. More particularly, the present invention relates to a self-assembling ligand composition comprising a ligand A separated at a hydrogen ion concentration (pH) condition of a certain range and a ligand B whose surface charge changes at a hydrogen ion concentration range of a specific range, A MRI contrast agent composition for cancer cell imaging comprising a ligand composition and MRI contrast-enhanced nanoparticles, and a method of producing the same. |
| priorityDate | 2014-09-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 76.